Number of 21 CFR 329.100(c)(1) citations per year
Subsection text: Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act.
You must be have a paid or trial subscription to view this content
Note: We offer new accounts a one week trial to see how they can reduce costs with better regulatory intelligence.
If you already have an account or want to sign up you can do so at one of the links below
Still skeptical? No worries! Not everything is behind a paywall and you can still: